American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3857)
  2. Hematologic Malignancies, Division of (3653)
  3. Center for Hematologic Malignancies (3552)
  4. GSK Faculty (1554)
  5. Adult Leukemia (1293)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (939)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (902)
  10. Tow Center for Developmental Oncology (TCDO) (865)
Search Within
Formats
  1. Meeting Abstract (4152)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3857)
  2. Hematologic Malignancies, Division of (3653)
  3. Center for Hematologic Malignancies (3552)
  4. GSK Faculty (1554)
  5. Adult Leukemia (1293)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (329)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (294)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (430)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5167)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5539)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vadastuximab talirine monotherapy in older patients with treatment naive CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Bixby, D. L.; Stein, A. S.; Fathi, A. T.; Kovacsovics, T. J.; Levy, M. Y.; Erba, H. P.; Lancet, J. E.; Jillella, A. P.; Ravandi, F.; Walter, R. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutated MYD88 zygosity and CXCR4 mutation status are important determinants of ibrutinib response and progression free survival in Waldenstrom's macroglobulinemia
    Meeting Abstract

    Treon, S. P.; Tsakmaklis, N.; Meid, K.; Yang, G.; Chen, J. J. G.; Liu, X.; Chen, J.; Demos, M.; Patterson, C. J.; Dubeau, T.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Ribosomal protein Rpl22 regulates development and transformation via altering RNA processing
    Meeting Abstract

    Wang, M.; Ser, Z.; Rao, S.; Fahl, S.; Zhang, Y.; Peri, S.; Kentsis, A.; Wiest, D. L.
    Blood (2016)

    Fulltext@MSK | Save
  • HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment
    Meeting Abstract

    Wang, Y. L.; Lu, P.; Lee, J.; Zhen, C. J.; Chiosis, G.; Guo, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Improved survival in AL amyloidosis: A population-based study on 1,430 patients diagnosed in Sweden 1995-2013
    Meeting Abstract

    Weiss, B. M.; Lund, S. H.; Bjorkholm, M.; Cohen, A. D.; Dember, L.; Landgren, O.; Kristinsson, S. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • Results of a phase Ib study of venetoclax plus R- or G-CHOP in patients with B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Zelenetz, A. D.; Salles, G. A.; Mason, K. D.; Casulo, C.; Le Gouill, S.; Sehn, L. H.; Tilly, H.; Cartron, G.; Chamuleau, M. E. D.; Goy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Astarabine, a novel leukemia-targeted cytarabine composition allows, for the first time, the delivery of high cytarabine doses for older or unfit patients with acute leukemia. Results of an ongoing phase I/IIa study
    Meeting Abstract

    Zuckerman, T.; Gengrinovitch, S.; Ben-Yakar, R.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Horowitz, N. A.; Nudelman, O.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039)
    Meeting Abstract

    Ansell, S.; Gutierrez, M. E.; Shipp, M. A.; Gladstone, D.; Moskowitz, A.; Borello, I.; Popa-Mckiver, M.; Farsaci, B.; Zhu, L.; Lesokhin, A. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparison of survival and costs of rituximab-based chemotherapy for initial therapy of follicular lymphoma in elderly patients
    Meeting Abstract

    Shah, G. L.; Winn, A.; Lin, P. J.; Kumar, A. J.; Parsons, S. K.
    Blood (2016)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic phase chronic myeloid leukemia (CML-CP) and in stable deep molecular response (DMR) to dasatinib - The DASFREE study
    Meeting Abstract

    Shah, N. P.; Paquette, R.; Müller, M. C.; Saussele, S.; Garcìa-Gutiérrez, V.; Jiménez-Velasco, A.; Nicolini, F. E.; Mauro, M. J.; Mahon, F. X.; Rea, D.; more...
    Blood (2016)

    Fulltext@MSK | Save